1. High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma. Issue 12 (3rd May 2018) Authors: Persico, M.; Aglitti, A.; Aghemo, A.; Rendina, M.; Lleo, A.; Ciancio, A.; Di Marco, V.; Lampertico, P.; Brunetto, M. R.; Zuin, M.; Andreone, P.; Villa, E.; Troshina, G.; Calvaruso, V.; Degasperi, E.; Coco, B.; Giorgini, A.; Conti, F.; Di Leo, A.; Marzi, L. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 12(2018) Page Start: 1705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.96 MODELING HEPATOCELLULAR CARCINOMA CELLS DYNAMICS BY SEROLOGICAL AND IMAGING BIOMARKERS TO EXPLAIN COMPLETE RESPONSE TO SORAFENIB. (September 2021) Authors: Colombatto, P.; Demirtas, C.O.; Ricco, G.; Civitano, L.; Boraschi, P.; Scalise, P.; Cavallone, D.; Oliveri, F.; Romagnoli, V.; Bleve, P.; Coco, B.; Salvati, A.; Urbani, L.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.88 THREE HBSAG KINETIC PROFILES IN HBEAG NEGATIVE INFECTION AND CHRONIC HEPATITIS ARE ASSOCIATED WITH DIFFERENT CHANCES OF HBSAG CLEARANCE. (September 2021) Authors: Colombatto, P.; Bleve, P.; Oliveri, F.; Cavallone, D.; Ricco, G.; Coco, B.; Romagnoli, V.; Salvati, A.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AF.89 CHANGING DEMOGRAPHIC-CLINIC-PATHOLOGIC PROFILES OF NEWLY DIAGNOSED CARRIERS OF CHRONIC HEPATITIS B VIRUS INFECTION ACROSS TWO DECADES: A SINGLE ITALIAN REFERENCE CENTER REPORT. (September 2021) Authors: Ricco, G.; Bleve, P.; Coco, B.; Cavallone, D.; Colombatto, P.; Oliveri, F.; Romagnoli, V.; Salvati, A.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AF.84 BIOIMAGING, BIOCHEMICAL AND GENETIC MARKERS TO STRATIFY PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN CLINICAL PRACTICE: A SINGLE CENTER COHORT STUDY. (September 2021) Authors: Salvati, A.; De Rosa, L.; Faita, F.; Cavallone, D.; Ricco, G.; Colombatto, P.; Coco, B.; Romagnoli, V.; Oliveri, F.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.04.9 A SINGLE CENTER, LARGE LONG TERM COHORT STUDY OF THE RELATIONS BETWEEN MUTATIONS IN BASIC-CORE-PROMOTER AND PRE-C REGIONS OF HEPATITIS B VIRUS DNA AND CLINICPATHOLOGIC OUTCOME OF HBEAG-NEGATIVE/ANTI-HBEPOSITIVE PHASE. (September 2021) Authors: Cavallone, D.; Ricco, G.; Flichman, D.; Moriconi, F.; Colombatto, P.; Bleve, P.; Coco, B.; Oliveri, F.; Romagnoli, V.; Salvati, A.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A multicentre prospective study response to treatment in genotype 3 and 1b infected patients with sickest liver cirrhosis: SVR 4 is not a reliable measure. (8th October 2016) Authors: Persico, M.; Rendina, M.; Di Marco, V.; Aghemo, A.; Brunetto, M.; Ciancio, A.; Zuin, M.; Andreone, P.; Villa, E.; Calvaruso, V.; De Nicola, S.; Coco, B.; Aglitti, A.; Toshina, Y.; Giorgini, A.; Conti, F.; Marzi, L.; Lleo, A.; Bollani, S.; Di Leo, A. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cancer cells and tumor vasculature dynamics analyzed by bio-mathematical modeling in HCC patients with different response to TKIs, TACE and TARE. (October 2022) Authors: Damone, F.; Colombatto, P.; Ricco, G.; Oliveri, F.; Civitano, L.; Romagnoli, V.; Cavallone, D.; Demirtas, C.O.; Boraschi, P.; Scalise, P.; Crocetti, L.; Bargellini, I.; Coco, B.; Salvati, A.; Surace, L.; Boni, G.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 3 Page Start: S166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy. Issue 1 (16th February 2017) Authors: Ricco, G.; Cavallone, D.; Pontisso, P.; Fassina, G.; Gallotta, A.; Colombatto, P.; Oliveri, F.; Romagnoli, V.; Coco, B.; Salvati, A.; Bonino, F.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparative antiviral efficacy with higher ALT normalization of tenofovir alafenamide (TAF) versus tenofovir disoproxil fumarate (TDF) in HBeAg-negative, genotype D chronic hepatitis B. Issue 1 (16th February 2017) Authors: Ricco, G.; Buti, M.; Omata, M.; Kim, Y.J.; Coco, B.; Samuel, D.; Flaherty, J.F.; Lin, L.; Gaggar, A.; Ceausu, E.; Akarca, U.S.; Tong, M.J.; Chan, H.L.; Brunetto, M.R. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗